Walmart expands free medicines: Walmart stock trades 1.41 percent above its Xetra close

Published on 10/15/2026 at 09:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

More than 250 prescriptions will be free for eligible workers in 2027. Walmart stock costs EUR 104.59 on October 15, 2026, 1.41 percent above its Xetra close.

Benefits and earnings calendar

Walmart announced more than 250 free prescriptions for eligible workers on October 13, 2026.
Fiscal second-quarter revenue reached USD 187.94 billion, up 5.90 percent year over year.
Walmart stock trades at EUR 104.59 at 9:35 a.m. CEST at Lang & Schwarz on October 15, 2026, 1.41 percent above the Xetra close of October 14, 2026.
Employee enrollment runs through November 6, 2026, and the new benefit takes effect on November 17, 2026.

Modernistisches Bauhaus-Plakatdesign mit geometrischen Primärfarben und abstrakten Einkaufswagen- und Regalsilhouetten — Walmart US9311421039 als Bauhaus Poster mit geometrischen Primärfarben und abstrakten Einzelhandel Motiven, Illustration mit AI erstellt.

Walmart (ISIN US9311421039) was trading at EUR 104.59 at Lang & Schwarz on October 15, 2026, at 9:35 a.m. CEST, 1.41 percent above the Xetra close of October 14, 2026 at EUR 103.14. The retailer's expanded employee health benefits provide the latest company-specific catalyst, with more than 250 prescriptions set to cost eligible workers nothing in 2027, according to Fox Business on October 14, 2026.

Benefits carry a measurable cost

The new package covers certain insulin products, inhalers and GLP-1 medicines for eligible employees with Type 2 diabetes. Starting premiums will rise by USD 1.50 per biweekly pay period to USD 39.80, while the company will also add specialist evaluations and up to 12 weeks of neonatal intensive care leave, Fox Business reported.

The benefit expansion is a workforce investment rather than a direct sales driver. Its financial effect matters because Walmart is simultaneously funding stores, technology and fulfillment capacity while trying to preserve operating leverage.

What does 5.90 percent growth mean?

Walmart's fiscal second-quarter revenue reached USD 187.94 billion, up 5.90 percent year over year, while adjusted earnings per share rose 19.10 percent to USD 0.81, according to Zacks on September 14, 2026. Walmart raised fiscal 2027 constant-currency sales growth guidance to 4.00 percent to 5.00 percent from 3.50 percent to 4.50 percent, but fiscal third-quarter operating income guidance is only 2.00 percent to 4.00 percent.

Three events set the chronology

On August 20, 2026, Walmart reported fiscal second-quarter revenue of USD 187.94 billion and adjusted earnings per share of USD 0.81, according to MarketBeat. On August 21, 2026, Telsey Advisory Group issued a USD 130.00 target, reduced from USD 140.00, in the same report. On October 13, 2026, Walmart announced the expanded prescription benefits for 2027, with more than 250 medicines included.

Two dates shape the next step

Walmart's annual benefits enrollment runs through November 6, 2026, and the expanded plan takes effect on November 17, 2026, according to Fox Business. The dates put the workforce initiative ahead of the next results cycle, where cost control and digital growth will remain central measures.

Stock stays below its yearly high

At EUR 104.59, Walmart's Lang & Schwarz price is within its EUR 84.64 to EUR 115.98 52-week range as of October 15, 2026. The current quote is 1.41 percent above the Xetra close of EUR 103.14 dated October 14, 2026, while the latest fiscal figures show earnings growth running faster than revenue.

The further course of trading is shown by the continuously updated real-time quote of Walmart stock.